A carregar...

Continuing need for mineralocorticoid therapy in salt-losing congenital adrenal hyperplasia.

Four patients with salt-losing congenital adrenal hyperplasia (CAH) who had stopped mineralocorticoid therapy for several years, showed raised plasma concentrations of 17OH-progesterone and plasma renin activity, despite adequate glucoticoid therapy. One patient was able to reduce urinary sodium exc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hughes, I A, Wilton, A, Lole, C A, Gray, O P
Formato: Artigo
Idioma:Inglês
Publicado em: 1979
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1545561/
https://ncbi.nlm.nih.gov/pubmed/475410
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!